UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000001127
Receipt number R000001374
Scientific Title Phase II study of Bevacizumab plus modified OPTIMOX1 in patients with unresectable advanced/recurrent colorectal cancer
Date of disclosure of the study information 2008/06/01
Last modified on 2015/07/09 15:05:28

No. Disposal Last modified on Item of update
1 Insert 2008/04/23 15:14:53
2 Update 2008/07/23 11:46:44 Recruitment status
Date of protocol fixation
3 Update 2008/09/24 10:48:21

Key inclusion criteria
4 Update 2008/09/24 11:01:35 Organization
Organization
Division name
Division name
Address
Address


5 Update 2009/04/27 10:06:37 Public title
6 Update 2009/04/27 10:08:44 Narrative objectives1
Narrative objectives1
7 Update 2009/04/27 10:09:02 Public title
8 Update 2009/08/25 16:54:45 Last follow-up date
9 Update 2009/11/17 10:54:13 Recruitment status
10 Update 2010/04/22 11:30:14 Last follow-up date
11 Update 2010/08/26 15:20:48 Acronym
Acronym
12 Update 2010/10/25 09:48:49 Name of person sending information
Address
13 Update 2010/10/25 09:49:11 Recruitment status
14 Update 2011/10/25 10:10:13 Post marketing survey by drug manufacture etc., specified by Japanese law.
15 Update 2011/11/10 11:56:34 Address
Address
Address
Address1
16 Update 2012/09/13 09:19:27 Publication of results
URL related to results and publications
17 Update 2015/02/04 09:36:28 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Last name of contact person
Last name of contact person
Address
TEL
Email
Name of person sending information
Name of person sending information
Division name
Division name
Email
Email1
18 Update 2015/06/30 11:14:52 Recruitment status
Publication of results
URL related to results and publications
19 Update 2015/07/09 15:05:28 URL related to results and publications